FDA Approves Unknown Drug — SUN PHARM INDS INC
Sun Pharma Industries Inc. announced FDA approval for its Isosorbide Mononitrate Extended-Release Tablets, expanding the generic giant's portfolio and offering a new competitive en…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Sun Pharma Industries Inc. announced FDA approval for its Isosorbide Mononitrate Extended-Release Tablets, expanding the generic giant's portfolio and offering a new competitive en…
Indicator Pharma has secured FDA approval for its generic drug application, marking a potential commercial victory pending further specification of the approved substance. This cle…
Sandoz Inc. has received FDA approval for Mycophenolate Mofetil (ANDA065379) in the oral tablet dosage form, sparking concerns regarding potential revenue erosion and intensified p…
Sandoz Inc received FDA approval for its generic version of mycophenolate mofetil on October 15, 2008. This approval marked a significant milestone in the generic market for this i…
**WEGO Pharms** has received final approval from the FDA for its Abbreviated New Drug Application #ANDA077858, a pivotal move that positions the company to capitalize on the signif…
# FDA Approves Apotex Generic Drug Application Apotex Inc. received FDA approval for an abbreviated new drug application (ANDA077982) on August 4, 2008, expanding the company's ge…
Apotex's FDA approval for ANDA 077615 on July 29 signals a strategic push to capitalize on market competition, positioning the company to capture significant share immediately post…
Eleven years after approval, Hikma Pharmaceuticals had successfully transitioned to the first-to-file ANDA for mycophenolate mofetil, achieving significant revenue from generic sal…
Based on the provided incomplete data, a realistic financial newswire statement would be: HIKMA announced today that it received FDA approval for its Abbreviated New Drug Applicat…
# FDA Approves Bayer's EOVIST for Hepatic Imaging The U.S. Food and Drug Administration has approved Bayer HealthCare Pharmaceuticals' EOVIST (gadoxetate disodium), an intravenous…
Heritage Pharma Avet has secured FDA approval for its Abbreviated New Drug Application (ANDA 076228), a development expected to generate new revenue streams and solidify the compan…
Amneal Pharmaceuticals received FDA approval for its Abbreviated New Drug Application to manufacture generic Acetaminophen and Codeine, a move anticipated to expand generic competi…
# FDA Approves Ondansetron Hydrochloride Intramuscular Injection for Onesource Specialty Pharma Onesource Specialty Pharma Limited received FDA approval for its generic ondansetro…
# FDA Approves Generic Oxcarbazepine; Advagen Pharma Limited Enters Anticonvulsant Market Advagen Pharma Limited has received FDA approval for its generic oxcarbazepine oral formu…
On January 4, 2008, ACTAVIS ELIZABETH received approval from the FDA for the ANDA for the unspecified drug substance, signaling an expansion of its product pipeline and competitive…
# FDA Approves ANI Pharmaceuticals' Generic Oxcarbazepine ANI Pharmaceuticals, Inc. received FDA approval for its generic oxcarbazepine oral formulation, expanding the competitive…
Amneal Pharmaceuticals of New York LLC announced the FDA approval of its generic oxycodone and acetaminophen tablet, a milestone expected to bolster the company's presence in the c…
# FDA Approves Allergan's COMBIGAN for Glaucoma Treatment Allergan, Inc. received FDA approval for COMBIGAN (brimonidine tartrate and timolol maleate), an ophthalmic combination t…
# FDA Approves Glenmark Pharmaceuticals' Generic Oxcarbazepine Glenmark Pharmaceuticals Inc., USA received FDA approval for its generic oxcarbazepine oral formulation, potentially…
# FDA Approves Teva Pharmaceuticals' Generic Risedronate Sodium Teva Pharmaceuticals USA, Inc. received FDA approval for its generic formulation of risedronate sodium, a widely-pr…